Oral liquid formulation of DPC-423 better than tablets according to pharmacokinetic analysis Sep. 25, 2001
FXV-673, a new factor Xa inhibitor, compares favorably to heparin in canine thrombosis model Sep. 12, 2001
Dose-finding trial results presented this week for new fibrin-specific thrombolytic agent Sep. 4, 2001
RSS